A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study Meeting Abstract

  

Authors:	Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
Abstract Title:	A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
Meeting Title:	44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	26
Issue:	15 Suppl.
Meeting Dates:	2008 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2008-05-20
Start Page:	66s
Language:	English
ACCESSION:	WOS:000208457400242
PROVIDER:	wos
DOI:	10.1200/jco.2008.26.15_suppl.1101
Notes:	Meeting Abstract: 1101 -- Source: Wos